Export Compliance Daily is a service of Warren Communications News.

New and Revised FDA Import Alerts for Oct. 16-22

On Oct. 16-22, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

Sign up for a free preview to unlock the rest of this article

Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.

  • 99-43: Ready-to-Eat Human (RTE) Food Products that appear to have been Prepared, Packed or Held Under Insanitary Conditions (here)
  • 99-39: Imported Food Products that appear to be Misbranded (here)
  • 99-38: Low-Acid Canned Foods or Acidified Foods due to Inadequate Process Control (here)
  • 99-34: Drugs or Medical Devices from firms without a valid Drug or Medical Device Registration (here)
  • 99-32: Products from firms refusing FDA Foreign Establishment Inspection (here)
  • 99-30: All Milk Products, Milk Derived Ingredients and Milk Containing Finished Food Products from China due to the presence of Melamine and/or Melamine Analogs (here)
  • 99-23: Produce due to contamination with Human Pathogens (here)
  • 99-19: Food Products due to the Presence of Salmonella (here)
  • 99-08: Processed Foods for Pesticides (here)
  • 99-05: Raw Agricultural Products for Pesticides (here)
  • 95-05: Electronic Products that fail to comply with Performance Standards or Have No Certification (here)
  • 85-02: Condoms (here)
  • 80-04: Surgeon's and Patient Examination Gloves (here)
  • 76-01: Medical Instruments from Pakistan (here)
  • 71-04: Animal Feeds, other than Pet Treats, due to the Presence of Salmonella (here).
  • 66-66: Active Pharmaceutical Ingredients (APIs) that appear to be misbranded Under 502(f)(1) because they do not meet the requirements for the Labeling Exemptions in 21 CFR 201.122 (here)
  • 66-41: Unapproved New Drugs Promoted in the U.S. (here)
  • 66-40: Drugs from firms which have not met Drug Good Manufacturing Practices (GMPs) (here)
  • 54-14: Dietary Supplement Products from firms which have not met Dietary Supplement Good Manufacturing Practices (GMPs) (here)
  • 45-02: Foods Containing Illegal and/or Undeclared Colors (here)
  • 16-129: Seafood Products due to Nitrofurans (here)
  • 16-127: All Seafood due to Chloramphenicol (here)
  • 16-125: Refrigerated (Not Frozen) Raw Fish and Fishery Products that are Vacuum Packaged or Modified Atmosphere Packaged or Packaged in a Material that is not Oxygen-Permeable due to the Potential for Clostridium Botulinum Toxin Production (here)
  • 16-124: Aquaculture Seafood Products due to Unapproved Drugs (here)
  • 16-81: Seafood Products due to the Presence of Salmonella (here).